about
Therapeutic potential of ultrasound microbubbles in gastrointestinal oncology: recent advances and future prospects.Improving the performance of phase-change perfluorocarbon droplets for medical ultrasonography: current progress, challenges, and prospects.Phase-transition thresholds and vaporization phenomena for ultrasound phase-change nanoemulsions assessed via high-speed optical microscopy.High-intensity focused ultrasound ablation enhancement in vivo via phase-shift nanodroplets compared to microbubbles.An evaluation of the sonoporation potential of low-boiling point phase-change ultrasound contrast agents in vitroReview on photoacoustic imaging of the brain using nanoprobesVaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validationBlinking Phase-Change Nanocapsules Enable Background-Free Ultrasound Imaging.Application of acoustic droplet vaporization in ultrasound therapy.Structural and functional photoacoustic molecular tomography aided by emerging contrast agents.Cavitation Enhancing Nanodroplets Mediate Efficient DNA Fragmentation in a Bench Top Ultrasonic Water Bath.Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.State-of-the-art materials for ultrasound-triggered drug delivery.Phase-shift perfluorocarbon agents enhance high intensity focused ultrasound thermal delivery with reduced near-field heating.Formation of toroidal bubbles from acoustic droplet vaporization.Initial nucleation site formation due to acoustic droplet vaporization.Indocyanine green-loaded photoacoustic nanodroplets: dual contrast nanoconstructs for enhanced photoacoustic and ultrasound imaging.In vitro parameter optimization for spatial control of focused ultrasound ablation when using low boiling point phase-change nanoemulsions.Effect of ultrasound on the permeability of vascular wall to nano-emulsion dropletsAcoustic droplet vaporization is initiated by superharmonic focusing.Current status and prospects for microbubbles in ultrasound theranostics.Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principleNanodroplet-mediated histotripsy for image-guided targeted ultrasound cell ablationMicrofluidic generation of acoustically active nanodroplets.Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imagingPhase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures.A targeted approach to cancer imaging and therapyMicrofluidic system for high throughput characterisation of echogenic particles.Contrast-enhanced ultrasound imaging in vivo with laser-activated nanodroplets.Noninvasive Targeted Transcranial Neuromodulation via Focused Ultrasound Gated Drug Release from Nanoemulsions.Nanobubbles: a promising efficient tool for therapeutic delivery.Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review.Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.Methods of Generating Submicrometer Phase-Shift Perfluorocarbon Droplets for Applications in Medical Ultrasonography.Neuromodulation with nanoparticles.A dual-mode hemispherical sparse array for three-dimensional passive acoustic mapping and skull localization within a clinical MRI guided focused ultrasound device.Breaking free from vascular confinement: status and prospects for submicron ultrasound contrast agents.On-chip preparation of nanoscale contrast agents towards high-resolution ultrasound imaging.Cavitation Enhancement Increases the Efficiency and Consistency of Chromatin Fragmentation from Fixed Cells for Downstream Quantitative Applications.
P2860
Q26777688-DFB1A33A-7D13-4E86-B233-F609BFB21476Q26861530-487AA086-D036-4F23-90FA-DD52497CB633Q27308582-17C57995-72E8-4539-B6A9-DE31C7EA7EF1Q30279234-DBEFDC0B-DF72-4107-9FC9-0C93BF2DC172Q30364987-2E7FA92B-35A5-445C-AD2B-3AD594902D6FQ30366218-F05BC044-4AA6-417E-A386-293D47F15F3AQ30370707-BB672A7D-492A-4011-B7A6-29FD8C8FAD53Q30375867-F26156F2-D66E-4D18-86AF-625E55EE56A2Q30398863-A510D962-ADEA-440F-B3BD-7B6D390DCED0Q30402942-A6294C09-E516-4904-8262-7C92516D2A3FQ30406409-0D960AC2-B4D6-41BC-B312-B6B7DF8AF056Q30408959-2F5DB0BC-B0B4-48CD-B771-6F354C50F376Q30409234-6F34D216-D09E-4A3E-9931-D1402F1B11B3Q30411555-39DE0BAA-925F-4C65-87F6-044787B86EA9Q30419065-C235DC14-C534-4930-A935-A404E202989BQ30419069-98989CF8-2B5F-4E80-9E16-7329F7776F51Q30420199-E4CC847B-39CD-47BA-BF4E-CF2AC6031664Q30422879-62CE6DE8-8133-4BDD-8BE5-42C48EC619D7Q30430028-2CD71700-8B2A-4B49-B626-863C155887E1Q30433518-6B05BFEB-1BFE-40DB-835C-1C462E9C214BQ30435874-FAB7FF5E-51DE-4A21-BB6B-CF91A8DB32DEQ30439339-DEC3E137-B8FD-4BD9-B38A-7147A6EFC96FQ30446270-3F6B9C0F-818C-462C-BA6D-523C3ACFA49DQ30453206-934A3B5E-6A89-41C6-B1F8-59E5EBBC827FQ30458493-F0176335-E95A-465A-9058-0DA400B16DE4Q33898006-E2CD3057-A262-40AF-8897-55700F9FFD32Q34523300-DED26592-29D9-44A3-AABB-0BB46A835ABAQ35390776-19DFA2D3-4E71-484B-B3DC-9A4A198F5F4FQ36341180-31645B05-AF29-46C8-BD81-7C44DF4B5DC0Q37716093-D904EE80-A483-4CDA-9B3A-984E65AA2160Q38697378-C98AFAD9-BCCF-4433-B413-736923146171Q38980428-E12B648B-FC13-4B67-870A-DCCCE82804FEQ41066998-8C11AB75-2993-41F4-9865-48CCA5AA0A61Q44867216-2B99DDA3-E275-486F-82E8-581F395D6ADAQ47105144-244FC361-9DF9-45C9-944B-0E294DFDA803Q47267027-2F521E98-EF9D-4193-A072-88967BBDB741Q49832195-64283DEC-F44D-43A1-87BF-D809D60647B6Q49931358-B627BBDF-D3D7-40E5-8588-5CC8338B9A33Q51473926-AD3FB1EA-7150-4A35-82F0-BBEC9CE66A98Q52586907-F1DB4822-DA81-4E4E-8D46-B2189A3984B0
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phase-change contrast agents for imaging and therapy.
@ast
Phase-change contrast agents for imaging and therapy.
@en
type
label
Phase-change contrast agents for imaging and therapy.
@ast
Phase-change contrast agents for imaging and therapy.
@en
prefLabel
Phase-change contrast agents for imaging and therapy.
@ast
Phase-change contrast agents for imaging and therapy.
@en
P2860
P1476
Phase-change contrast agents for imaging and therapy
@en
P2093
Paul A Dayton
P2860
P304
P356
10.2174/138161212800099883
P577
2012-01-01T00:00:00Z